Suppr
超能文献

Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults.

作者信息

Ryder S D

机构信息

Queens Medical Centre, Nottingham NG7 2UH, UK.

出版信息

Gut. 2003 May;52 Suppl 3(Suppl 3):iii1-8. doi: 10.1136/gut.52.suppl_3.iii1.

DOI:10.1136/gut.52.suppl_3.iii1

PMID:12692148

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1867754/

Abstract

摘要

相似文献

Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults.

Gut. 2003 May;52 Suppl 3(Suppl 3):iii1-8. doi: 10.1136/gut.52.suppl_3.iii1.

Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma.

Minerva Gastroenterol Dietol. 2009 Jun;55(2):123-38.

Current approach to hepatocellular carcinoma.

Surg Clin North Am. 2010 Aug;90(4):803-16. doi: 10.1016/j.suc.2010.04.010. Epub 2010 Jun 8.

Hepatocellular cancer.

West Indian Med J. 2009 Jun;58(3):273-6.

[Scrutiny and management of a patient with hepatocarcinoma].

Rev Gastroenterol Mex. 2005 Nov;70 Suppl 3:69-70.

Optimal management of hepatocellular carcinoma: challenges and opportunities.

J Gastroenterol Hepatol. 2010 Aug;25(8):1336-8. doi: 10.1111/j.1440-1746.2010.06373.x.

Management of hepatocellular carcinoma in the age of liver transplantation.

Int J Surg. 2009 Aug;7(4):324-9. doi: 10.1016/j.ijsu.2008.12.041. Epub 2009 Jan 6.

Hepatocellular carcinoma in a case of Wilson's disease treated with radiofrequency ablation therapy.

Intern Med. 2011;50(13):1433-7. doi: 10.2169/internalmedicine.50.5203. Epub 2011 Jul 1.

Hepatocellular carcinoma: status in the era of liver transplantation.

J Okla State Med Assoc. 2009 Dec;102(12):355-61.

Hepatocellular carcinoma: current management.

Curr Probl Surg. 2010 Jan;47(1):10-67. doi: 10.1067/j.cpsurg.2009.09.003.

引用本文的文献

Prevalence and risk factors of portal vein thrombosis following hepatectomy: a systematic review and meta‑analysis.

Wideochir Inne Tech Maloinwazyjne. 2025 Jan 15;20(1):36-43. doi: 10.20452/wiitm.2025.17929. eCollection 2025 Apr 9.

FCGR2A contributes to M2 macrophages polarization in HCC through IL-4/JAK/STAT6 axis.

Transl Oncol. 2025 Aug;58:102429. doi: 10.1016/j.tranon.2025.102429. Epub 2025 Jun 6.

Isolated calvarial lesion as the initial presentation of metastatic hepatocellular carcinoma: A case report and review of the literature.

Surg Neurol Int. 2025 Jan 10;16:6. doi: 10.25259/SNI_507_2024. eCollection 2025.

Differentiating Well-Differentiated from Poorly-Differentiated HCC: The Potential and the Limitation of Gd-EOB-DTPA in the Presence of Liver Cirrhosis.

Diagnostics (Basel). 2024 Aug 2;14(15):1676. doi: 10.3390/diagnostics14151676.

Current and Emerging Molecular Markers of Liver Diseases: A Pathogenic Perspective.

Gene Expr. 2022;21(1):9-19. doi: 10.14218/gejlr.2022.00010. Epub 2022 Sep 28.

CASCADE: Context-Aware Data-Driven AI for Streamlined Multidisciplinary Tumor Board Recommendations in Oncology.

Cancers (Basel). 2024 May 23;16(11):1975. doi: 10.3390/cancers16111975.

Ultrasensitive dynamic light scattering immunodetection of alpha-fetoprotein using heptamer-amplified nanoparticle crosslinking aggregation.

Mikrochim Acta. 2024 Jun 13;191(7):387. doi: 10.1007/s00604-024-06437-7.

The Synergy of Gene Targeting Drug Icaritin Soft Capsule with Immunomodulator and TACE Brings New Hope for Drug Combination in Patients with Advanced Liver Cancer: A Case Report and Literature Review.

Cancer Manag Res. 2023 Jul 18;15:707-717. doi: 10.2147/CMAR.S414487. eCollection 2023.

Recent Advances in Locoregional Therapy of Hepatocellular Carcinoma.

Cancers (Basel). 2023 Jun 26;15(13):3347. doi: 10.3390/cancers15133347.

A convoluted path to the diagnosis of hepatocellular carcinoma in a resource-limited setting.

SAGE Open Med Case Rep. 2023 Apr 25;11:2050313X231168292. doi: 10.1177/2050313X231168292. eCollection 2023.

本文引用的文献

A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma.

Hepatology. 2002 Sep;36(3):687-91. doi: 10.1053/jhep.2002.35071.

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial.

Lancet. 2002 May 18;359(9319):1734-9. doi: 10.1016/S0140-6736(02)08649-X.

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma.

Hepatology. 2002 May;35(5):1164-71. doi: 10.1053/jhep.2002.33156.

Short-term results of radiofrequency ablation in liver tumors.

Am J Surg. 2000 Jun;179(6):527. doi: 10.1016/s0002-9610(00)00254-3.

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial.

Lancet. 2000 Sep 2;356(9232):802-7. doi: 10.1016/S0140-6736(00)02654-4.

Percutaneous microwave coagulation therapy for superficial hepatocellular carcinoma on the liver surface.

Am J Gastroenterol. 2000 Sep;95(9):2401-3. doi: 10.1111/j.1572-0241.2000.02355.x.

Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis.

Ann Surg. 2000 Sep;232(3):381-91. doi: 10.1097/00000658-200009000-00010.

Effectiveness of interferon therapy for reducing the incidence of hepatocellular carcinoma among patients with type C chronic hepatitis.

J Epidemiol. 2000 Jul;10(4):234-40. doi: 10.2188/jea.10.234.

Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: a retrospective cohort study of 738 patients.

Int J Cancer. 2000 Sep 1;87(5):741-9.

Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival.

Hepatology. 2000 Aug;32(2):233-8. doi: 10.1053/jhep.2000.9603.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译